Post-mortem examination of high mortality in patients with heart failure and atrial fibrillation

• Published in: BMC medicine Vol. 20; no. 1; pp. 331 - 11
• Main Authors: Țica, Otilia, Țica, Ovidiu, Bunting, Karina V, deBono, Joseph, Gkoutos, Georgios V, Popescu, Mircea I, Kotecha, Dipak
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 05.10.2022; BioMed Central; BMC
• Subjects: Age; Aged; Aged, 80 and over; Analysis; Anticoagulants; Atrial fibrillation; Atrial Fibrillation - complications; Atrial Fibrillation - diagnosis; Autopsies; Autopsy; Blood pressure; Cardiac arrhythmia; Cardiovascular disease; Clinical medicine; Congestive heart failure; Death; Diabetes; Ejection fraction; Electronic health records; Female; Fibrillation; Health hazards; Heart Failure; Humans; Hypertension; Male; Medical records; Middle Aged; Missing data; Mortality; Patient outcomes; Patients; Post-mortem; Prognosis; Retrospective Studies; Risk Factors; Statistical analysis; Stroke; Stroke Volume; Thromboembolism; Ventricle; Ventricular Function, Left; Romania; Heart failure; Post-mortem; Autopsy; Atrial fibrillation; Mortality
• ISSN: 1741-7015; 1741-7015
• DOI: 10.1186/s12916-022-02533-8

The prevalence of combined heart failure (HF) and atrial fibrillation (AF) is rising, and these patients suffer from high rates of mortality. This study aims to provide robust data on factors associated with death, uniquely supported by post-mortem examination. A retrospective cohort study of hospitalized adults with a clinical diagnosis of HF and AF at a tertiary centre in Romania between 2014 and 2017. A standardized post-mortem examination was performed where death occurred within 24 h of admission, when the cause of death was not clear or by physician request. National records were used to collect mortality data, subsequently categorized and analysed as HF-related death, vascular death and non-cardiovascular death using Cox proportional hazards regression. A total of 1009 consecutive patients with a mean age of 73 ± 11 years, 47% women, NYHA class 3.0 ± 0.9, left ventricular ejection fraction (LVEF) 40.1 ± 11.0% and 100% anticoagulated were followed up for 1.5 ± 0.9 years. A total of 291 (29%) died, with post-mortems performed on 186 (64%). Baseline factors associated with mortality were dependent on the cause of death. HF-related death in 136 (47%) was associated with higher NYHA class (hazard ratio [HR] 2.45 per one class increase, 95% CI 1.73-3.46; p < 0.001) and lower LVEF (0.95 per 1% increase, 0.93-0.97; p < 0.001). Vascular death occurred in 75 (26%) and was associated with hypertension (HR 2.83, 1.36-5.90; p = 0.005) and higher LVEF (1.08 per 1% increase, 1.05-1.11; p < 0.001). Non-cardiovascular death in 80 (28%) was associated with clinical obesity (HR 2.20, 1.21-4.00; p = 0.010) and higher LVEF (1.10 per 1% increase, 1.06-1.13; p < 0.001). Across all causes, there was no relationship between mortality and AF type (p = 0.77), HF type (p = 0.85) or LVEF (p = 0.58). Supported by post-mortem data, the cause of death in HF and AF patients is heterogeneous, and the relationships with typical markers of mortality are critically dependent on the mode of death. The poor prognosis in this group demands further attention to improve management beyond anticoagulation.